Gene Targeting in Rat Spermatogonial Stem Cells

大鼠精原干细胞的基因靶向

• 批准号: 7239783
• 负责人: F. Kent Hamra
• 金额: $ 19.63万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-06-15 至 2009-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7239783
• 关键词: 1q32; Alleles; Animal Model; Biology; Cardiovascular system; Cell Line; Cell Therapy; Culture Media; Disease; Drug Addiction; Event; Galactosidase; Ganciclovir; Gastrointestinal Diseases; Gene Targeting; Genes; Genetic Recombination; Genomics; Germ; Germ Cells; Germ Lines; Goals; Human; Immune System Diseases; Kidney Diseases; Knock-in Mouse; Knock-out; Laboratories; Laboratory Rat; Lung diseases; Medical; Medicine; Methods; Modeling; Modification; Molecular Biology; Mus; Nature; Neurologic; Partner in relationship; Physiology; Plasmids; Public Health; Rattus; Reagent; Reproduction; Research; Science; Scientist; Sensory Disorders; Site; Spermatogenesis; Stem cells; Techniques; Technology; Testing; Testis; Transfection; Transgenic Model; Transgenic Organisms; Transplantation; aging nutrition; antibiotic G 418; base; blastomere structure; embryonic stem cell; gene function; gene replacement; homologous recombination; interest; new technology; nuclear transfer; olfactory marker protein; recombinase; reconstitution; sperm cell; transgene expression; transmission process; vector

DESCRIPTION (provided by applicant): The goal of this project is to significantly impact biology and medicine by establishing gene targeting technology in the rat using spermatogonial stem cells given pluripotent rat ES cells have not been obtained. The rat represents the most widely used laboratory-scale mammalian model for human physiology and disease. However, despite its wide popularity in science, technology to produce rats with targeted genomic modifications has yet to be established. Therefore, one long-term goal of this application is to develop technology that will allow scientists to use spermatogonial stem cells to produce transgenic rat models with specific genomic modifications; such animal models will represent alternatives to the mouse in terms of answering important health-related questions. A second long term goal of this application will be to use the generated technology to unravel the molecular biology, physiology and pluripotent nature of spermatogonial stem cells. To realize these long-term goals, the immediate goals in this proposal are to genetically modify rat spermatogonial stem cells in culture at defined genomic sites by using Cre-lox (Specific Aim 1) and homologous recombination (Specific Aim 2) technology. The modified stem cells will be expanded in culture using positive and negative selectable markers. The selected lines will be transplanted into rat testes where they will develop into transgenic spermatozoa and then used for germline transmission of the targeted rat alleles through natural mating. Due to the popularity of the laboratory rat in science, animal models generated using sperm stem cells by the proposed technology will have a positive impact on public health issues by greatly facilitating research in many different medical fields. This would include studies in the rat on neurological and sensory disorders, drug addiction, cardiovascular and renal disease, immune disease, gastrointestinal disease, pulmonary disorders, nutrition, aging, reproduction and cell based therapies. Due to the popularity of the laboratory rat in science, animal models generated using sperm stem cells by the proposed technology will have a positive impact on public health issues by greatly facilitating research in many different medical fields. This would include studies in the rat on neurological and sensory disorders, drug addiction, cardiovascular and renal disease, immune disease, gastrointestinal disease, pulmonary disorders, nutrition, aging, reproduction and cell based therapies.

描述（由申请人提供）：该项目的目标是在尚未获得多能大鼠 ES 细胞的情况下，利用精原干细胞在大鼠中建立基因靶向技术，从而显着影响生物学和医学。大鼠代表了用于人类生理学和疾病的最广泛使用的实验室规模哺乳动物模型。然而，尽管其在科学上广泛流行，但生产具有靶向基因组修饰的大鼠的技术尚未建立。因此，该应用的一个长期目标是开发一种技术，使科学家能够利用精原干细胞来产生具有特定基因组修饰的转基因大鼠模型；在回答重要的健康相关问题方面，此类动物模型将成为小鼠的替代品。该应用的第二个长期目标是利用所产生的技术来揭示精原干细胞的分子生物学、生理学和多能性质。为了实现这些长期目标，本提案的近期目标是通过使用 Cre-lox（具体目标 1）和同源重组（具体目标 2）技术，对培养物中指定基因组位点的大鼠精原干细胞进行基因修饰。修饰的干细胞将使用阳性和阴性选择标记在培养物中扩增。选定的品系将被移植到大鼠睾丸中，在那里它们将发育成转基因精子，然后通过自然交配用于目标大鼠等位基因的种系传递。由于实验室大鼠在科学中的普及，通过所提出的技术使用精子干细胞生成的动物模型将极大地促进许多不同医学领域的研究，从而对公共健康问题产生积极影响。这将包括对大鼠进行神经和感觉疾病、药物成瘾、心血管和肾脏疾病、免疫疾病、胃肠道疾病、肺部疾病、营养、衰老、生殖和细胞疗法的研究。由于实验室大鼠在科学中的普及，通过所提出的技术使用精子干细胞生成的动物模型将极大地促进许多不同医学领域的研究，从而对公共健康问题产生积极影响。这将包括对大鼠进行神经和感觉疾病、药物成瘾、心血管和肾脏疾病、免疫疾病、胃肠道疾病、肺部疾病、营养、衰老、生殖和细胞疗法的研究。